Endpoint
Transepidermal water loss (TEWL)
CAT:outcome/transepidermal-water-lossreported in g/m^2/h
How it is measured
Water flux through the epidermis by open- or closed-chamber evaporimetry (tewametry) at a defined anatomical site, under controlled room temperature and humidity after a stated acclimatisation period. Site, device and acclimatisation conditions are recorded with each finding, and sites are reported separately.
Measured, not recorded
- Subject
- transepidermal water loss (tewl)
- Measurements
- 6 measurements
- Recorded as a finding
- No
Show what was measured
transepidermal water loss (TEWL)
decreases
At 70 days, TEWL in both the 0.01% and 0.1% astaxanthin-supplemented groups was significantly lower than that in the control UVA-irradiated group
PMID:28170435 · one of two readings recorded this
transepidermal water loss (TEWL)
unclear
which demonstrated a trend toward suppression by dietary astaxanthin at 56 days
PMID:28170435 · one of two readings recorded this
transepidermal water loss (TEWL)
decreases
TEWL was low in CP 1000 mg/kg-treated group and N-acetyl glucosamine (NAG) group after five weeks
PMID:30423867 · one of two readings recorded this
transepidermal water loss (TEWL)
decreases, 49.52% reduction vs 36.96% in control
TEWL was reduced from baseline by 49.52% after administrating with 2 mg/d of ASX and 3 mg/d of collagen hydrolysate for 12 weeks while there was a 36.96% of TEWL reduction in the control group.
PMID:34578794 · one of two readings recorded this
transepidermal water loss (TEWL)
decreases, improved 15% (arm) / 10% (cheek), p = 0.002, n = 24
Specifically, TEWL improved by 15% (p = 0.002) and skin erythema improved by 12% (p = 0.002).
PMID:40259621 · one of two readings recorded this
Transepidermal water loss (TEWL)
increases
Not recorded as a finding: the paper never states the instrument the node requires
The Ashwagandha group demonstrated greater improvement in TEWL and a substantial improvement in hair-related parameters (density, growth, anagen, telogen, and anagen: telogen ratio) compared to Placebo (p < 0.05) on day 75.
PMID:41770039 · one of two readings recorded this